Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective of this study is to demonstrate that a rifampin-free regimen is non-inferior to the rifampin-containing regimen in terms of all-cause mortality in staphylococcal prosthetic valve endocarditis within 6 months after randomization.
Epistemonikos ID: 6ffcc813406ac14fd48595ff828bcd5bfde11ab9
First added on: Jan 16, 2026